Compact Generation Flow Cytometers Offer Total Workflow Solution
|
By LabMedica International staff writers Posted on 30 Jul 2009 |
Compact, affordable flow cytometers offer a total workflow solution that will include optimized reagent kits for clinical and life science applications, as well as in-field service. The new flow cytometers will permit laboratory personnel to conduct analyses at their benchtops.
The new guava easyCyteT 8HT flow cytometry system is a compact, six-color detection system with 96-well automation. Six targets and eight parameters can be simultaneously analyzed in a single sample of cells. The system allows freedom to choose fluorescent dyes with well-separated emission spectra, which reduces the chance of overlap in the resulting signals and improves data quality.
The easyCyte 8HT system utilizes microcapillary technology that reduces the number of cells needed for analysis and the amount of waste generated--from liters per day with traditional approaches to less than 50 mL per day. Elimination of complicated fluidics gives the instrument a small footprint and dramatically decreases user maintenance.
The InCyte software allows investigators to view, compare, and analyze up to eight data sets simultaneously. This means that entire plates of data can be analyzed in less time than it currently takes to analyze data from a single sample using traditional software.
The new generation Guava easyCyteT 8HT flow cytometry system was launched by Millipore Corp. (Billerica, MA, USA) a provider of technologies, tools, and services for the global life science industry. It is the first instrument introduced by Millipore since its acquisition of Guava Technologies, a provider of benchtop flow cytometers, in February 2009.
Related Links:
Millipore Corp.
The new guava easyCyteT 8HT flow cytometry system is a compact, six-color detection system with 96-well automation. Six targets and eight parameters can be simultaneously analyzed in a single sample of cells. The system allows freedom to choose fluorescent dyes with well-separated emission spectra, which reduces the chance of overlap in the resulting signals and improves data quality.
The easyCyte 8HT system utilizes microcapillary technology that reduces the number of cells needed for analysis and the amount of waste generated--from liters per day with traditional approaches to less than 50 mL per day. Elimination of complicated fluidics gives the instrument a small footprint and dramatically decreases user maintenance.
The InCyte software allows investigators to view, compare, and analyze up to eight data sets simultaneously. This means that entire plates of data can be analyzed in less time than it currently takes to analyze data from a single sample using traditional software.
The new generation Guava easyCyteT 8HT flow cytometry system was launched by Millipore Corp. (Billerica, MA, USA) a provider of technologies, tools, and services for the global life science industry. It is the first instrument introduced by Millipore since its acquisition of Guava Technologies, a provider of benchtop flow cytometers, in February 2009.
Related Links:
Millipore Corp.
Latest Hematology News
- Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
- Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
- Higher Ferritin Threshold May Improve Iron Deficiency Detection in Children
- Stem Cell Biomarkers May Guide Precision Treatment in Acute Myeloid Leukemia
- Advanced CBC-Derived Indices Integrated into Hematology Platforms
- Blood Test Enables Early Detection of Multiple Myeloma Relapse
- Single Assay Enables Rapid HLA and ABO Genotyping for Transplant Matching
- Prognostic Biomarker Identified in Diffuse Large B-Cell Lymphoma
- Routine Blood Test Parameters Link Anemia to Cancer Risk and Mortality
- Prognostic Tool Guides Personalized Treatment in Rare Blood Cancer
- New Platelet Function Assay Enables Monitoring of Antiplatelet Therapy
- Open Multi-Omics Platform Identifies Prognostic Subtypes in Blood Cancers
- AI-Powered Digital Workflow Standardizes Bone Marrow Aspirate Morphology
- Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis
- New Guidelines Aim to Improve AL Amyloidosis Diagnosis
- Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
Channels
Clinical Chemistry
view channel
Saliva-Based Test Detects Biochemical Signs of Sleep Loss
Acute sleep loss impairs cognition and motor skills, raising safety risks that resemble alcohol intoxication. Clinicians currently lack an objective biochemical test to determine when someone is dangerously... Read more
Simple Dual-Tau Blood Test Detects and Stages Alzheimer’s Disease
Alzheimer’s disease is typically confirmed and staged with positron emission tomography scans and cerebrospinal fluid testing, procedures that are costly and invasive. Broader access to minimally invasive... Read more
Alzheimer’s Blood Biomarkers Linked to Early Cognitive Differences Before Dementia
Blood-based screening for Alzheimer’s disease offers a noninvasive, lower-cost alternative to brain imaging or spinal fluid testing, yet its ability to flag the earliest cognitive changes has been unclear.... Read moreMolecular Diagnostics
view channel
New PCR Assay Supports Bundibugyo Ebola Outbreak Surveillance
Rapid identification of Ebola infections is essential to limit transmission and guide public health response, yet detection can be difficult when outbreaks involve rare variants. The current outbreaks... Read more
Plasma Protein Signature Predicts Lung Cancer Risk Up to Five Years Ahead
Lung cancer remains a leading cause of cancer death, and many cases are detected only after symptoms appear. Current screening programs largely target people with a history of smoking, leaving other at-risk... Read moreHematology
view channel
Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more
Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
Immune checkpoint inhibitors have improved outcomes across many cancers, yet only a subset of patients derive durable benefit and biomarkers to guide treatment remain limited. Eosinophils, best known for... Read moreImmunology
view channelAptamer-Based Biosensor Enables Mutation-Resilient SARS-CoV-2 Detection
Rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can undermine existing molecular diagnostics, especially when assays target small viral components. Double-antibody sandwich... Read more
Study Points to Autoimmune Pathway Behind Long COVID Symptoms
Long COVID leaves many SARS-CoV-2 survivors with persistent fatigue, cognitive issues, palpitations, and musculoskeletal pain for months or years. Estimates cited in new research suggest 4%–20% of infected... Read more
Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response
Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read moreMicrobiology
view channel
New Culture Medium Speeds C. difficile Resistance Detection and Reduces Costs
Clostridioides difficile infections remain a persistent threat in hospitals and communities, affecting about 500,000 people in the United States each year. Severe cases can be fatal within 30 days of diagnosis,... Read more
Automated Blood Culture System Speeds Detection of Bloodstream Infections
Bloodstream infections and sepsis require rapid laboratory detection to guide targeted antimicrobial therapy and reduce mortality. Conventional blood culture workflows can delay actionable results by critical... Read morePathology
view channel
3D Spatial Multi-Omics Maps Intra-Tumor Diversity in Colorectal Cancer
Colorectal cancer remains a leading cause of cancer death, and clinical decision-making is complicated by marked intra-tumor heterogeneity. Conventional bulk sequencing averages molecular signals across... Read more
Blood-Based Method Tracks Gene Activity in the Living Brain
Real-time measurement of gene activity in the brain has been limited by assays requiring destructive tissue sampling. Tracking active genes could reveal how the body responds to environmental factors,... Read moreIndustry
view channel
Collaboration Advances ctDNA-Guided Development in Metastatic Colorectal Cancer
Natera, Inc. (Austin, TX, USA) and CytoDyn Inc. (Vancouver, WA, USA) announced a strategic collaboration focused on metastatic colorectal cancer (mCRC). Under the agreement, Natera will evaluate circulating... Read more








